Skip to main content

Advertisement

SpringerLink
Log in

Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We evaluated the effectiveness of supplementation with high dose of oral vitamin D3 to correct vitamin D insufficiency. We have shown that one or two oral bolus of 300,000 IU of vitamin D3 can correct vitamin D insufficiency in 50% of patients and that the patients who benefited more from supplementation were those with the lowest baseline levels.

Introduction

Adherence with daily oral supplements of vitamin D3 is suboptimal. We evaluated the effectiveness of a single high dose of oral vitamin D3 (300,000 IU) to correct vitamin D insufficiency in a rheumatologic population.

Methods

Over 1 month, 292 patients had levels of 25-OH vitamin D determined. Results were classified as: deficiency <10 ng/ml, insufficiency ≥10 to 30 ng/ml, and normal ≥30 ng/ml. We added a category using the IOM recommended cut-off of 20 ng/ml. Patients with deficient or normal levels were excluded, as well as patients already supplemented with vitamin D3. Selected patients (141) with vitamin D insufficiency (18.5 ng/ml (10.2–29.1) received a prescription for 300,000 IU of oral vitamin D3 and were asked to return after 3 (M3) and 6 months (M6). Patients still insufficient at M3 received a second prescription for 300,000 IU of oral vitamin D3. Relation between changes in 25-OH vitamin D between M3 and M0 and baseline values were assessed.

Results

Patients (124) had a blood test at M3. Two (2%) had deficiency (8.1 ng/ml (7.5–8.7)) and 50 (40%) normal results (36.7 ng/ml (30.5–5.5)). Seventy-two (58%) were insufficient (23.6 ng/ml (13.8–29.8)) and received a second prescription for 300,000 IU of oral vitamin D3. Of the 50/124 patients who had normal results at M3 and did not receive a second prescription, 36 (72%) had a test at M6. Seventeen (47%) had normal results (34.8 ng/ml (30.3–42.8)) and 19 (53%) were insufficient (25.6 ng/ml (15.2–29.9)). Of the 72/124 patients who receive a second prescription, 54 (75%) had a test at M6. Twenty-eight (52%) had insufficiency (23.2 ng/ml (12.8–28.7)) and 26 (48%) had normal results (33.8 ng/ml (30.0–43.7)). At M3, 84% patients achieved a 25-OH vitamin D level >20 ng/ml. The lowest the baseline value, the highest the change after 3 months (negative relation with a correlation coefficient r = −0.3, p = 0.0007).

Conclusions

We have shown that one or two oral bolus of 300,000 IU of vitamin D3 can correct vitamin D insufficiency in 50% of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bischoff-Ferrari HA et al (2008) Severe vitamin D deficiency in Swiss hip fracture patients. Bone 42(3):597–602

    Article  PubMed  CAS  Google Scholar 

  2. Chapuy MC et al (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327(23):1637–1642

    Article  PubMed  CAS  Google Scholar 

  3. Bischoff-Ferrari HA et al (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692

    Article  PubMed  CAS  Google Scholar 

  4. Bischoff-Ferrari HA et al (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169(6):551–561

    Article  PubMed  CAS  Google Scholar 

  5. Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326(7387):469

    Article  PubMed  CAS  Google Scholar 

  6. Crew KD et al (2009) High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27(13):2151–2156

    Article  PubMed  CAS  Google Scholar 

  7. Dawson-Hughes B et al (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporosis Int 21(7):1151–1154

    Article  CAS  Google Scholar 

  8. Rosen CJ (2011) Clinical practice. Vitamin D insufficiency. N Engl J Med 364(3):248–254

    Article  PubMed  CAS  Google Scholar 

  9. Sai AJ et al (2011) Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 96(3):E436–E446

    Article  PubMed  CAS  Google Scholar 

  10. Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79–84

    Article  PubMed  Google Scholar 

  11. Gallagher JC, Sai AJ (2010) Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab 95(6):2630–2633

    Article  PubMed  CAS  Google Scholar 

  12. Tang BM et al (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370(9588):657–666

    Article  PubMed  CAS  Google Scholar 

  13. Stoll D et al (2011) High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population. Swiss Med Wkly 141:w13196

    PubMed  Google Scholar 

  14. Ross AC et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58

    Article  PubMed  CAS  Google Scholar 

  15. Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930

    Article  PubMed  CAS  Google Scholar 

  16. Sanders KM (2010) In older patients with hip fracture, extended physiotherapy reduces falls compared with standard physiotherapy, and high dose cholecalciferol reduces hospital readmissions compared with lower dose. Evid Based Med 15(5):144–145

    Article  PubMed  Google Scholar 

  17. Sanders KM et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303(18):1815–1822

    Article  PubMed  CAS  Google Scholar 

  18. Lai JK et al (2010) Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health 10:331

    Article  PubMed  Google Scholar 

  19. Ilahi M, Armas LA, Heaney RP (2008) Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 87(3):688–691

    PubMed  CAS  Google Scholar 

  20. Wu F et al (2003) Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N Z Med J 116(1179):U536

    PubMed  Google Scholar 

  21. Bacon CJ et al (2009) High-dose oral vitamin D3 supplementation in the elderly. Osteoporosis Int 20(8):1407–1415

    Article  CAS  Google Scholar 

  22. Krieg MA et al (1999) Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporosis Int 9(6):483–488

    CAS  Google Scholar 

  23. von Restorff C, Bischoff-Ferrari HA, Theiler R (2009) High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone 45(4):747–749

    Article  Google Scholar 

  24. Reid D et al (2011) The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 93(5):1006–1011

    Article  PubMed  CAS  Google Scholar 

  25. Smith H et al (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 46(12):1852–1857

    Article  CAS  Google Scholar 

  26. Leventis P, Kiely PD (2009) The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 38(2):149–153

    Article  PubMed  CAS  Google Scholar 

  27. Premaor MO et al (2008) The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab 26(6):603–608

    Article  PubMed  CAS  Google Scholar 

  28. Romagnoli E et al (2008) Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 93(8):3015–3020

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

There is no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.

Author information

Authors and Affiliations

  1. Center for Bone Diseases, University Hospital of Lausanne, Lausanne, Switzerland

    D. Stoll, O. Lamy, D. Hans, M. A. Krieg & B. Aubry-Rozier

  2. Division of Rheumatology, University Hospital of Lausanne, Lausanne, Switzerland

    J. Dudler & B. Aubry-Rozier

  3. Department of Rheumatology, HFR Fribourg—Fribourg Cantonal Hospital, Fribourg, Switzerland

    J. Dudler

  4. Lausanne University Hospital (CHUV) – DAL, Avenue Pierre Decker 4, 1011, Lausanne, Switzerland

    D. Stoll

Authors
  1. D. Stoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Dudler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Lamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Hans
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. A. Krieg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Aubry-Rozier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Stoll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoll, D., Dudler, J., Lamy, O. et al. Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?. Osteoporos Int 24, 495–500 (2013). https://doi.org/10.1007/s00198-012-1962-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-012-1962-5

Keywords

Search

Navigation